Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS SE & CO. KGAA

(FRE)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 06/16 03:58:53 pm
45.358 EUR   -0.29%
06/10FRESENIUS SE  : Buy rating from Goldman Sachs
MD
06/10PRESS RELEASE : SphingoTec Expands Management Team and Appoints new CFO
DJ
06/09DGAP-DD : Fresenius Medical Care AG & Co. KGaA english
DJ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
06/10/2021 06/11/2021 06/14/2021 06/15/2021 06/16/2021 Date
45.27(c) 45.255(c) 45.16(c) 45.49(c) 45.555 Last
1 074 548 706 541 1 009 952 757 208 991 928 Volume
+0.08% -0.03% -0.21% +0.73% +0.14% Change
More quotes
Financials
Sales 2021 36 933 M 44 295 M 44 295 M
Net income 2021 1 783 M 2 138 M 2 138 M
Net Debt 2021 22 136 M 26 549 M 26 549 M
P/E ratio 2021 14,2x
Yield 2021 1,88%
Sales 2022 39 081 M 46 872 M 46 872 M
Net income 2022 2 048 M 2 456 M 2 456 M
Net Debt 2022 20 716 M 24 846 M 24 846 M
P/E ratio 2022 12,2x
Yield 2022 2,05%
Capitalization 25 399 M 30 779 M 30 462 M
EV / Sales 2021 1,29x
EV / Sales 2022 1,18x
Nbr of Employees 310 842
Free-Float 73,0%
More Financials
Company
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (48.6%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (32.4%;... 
More about the company
Ratings of Fresenius SE & Co. KGaA
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about FRESENIUS SE & CO. KGAA
06/10FRESENIUS SE  : Buy rating from Goldman Sachs
MD
06/10PRESS RELEASE : SphingoTec Expands Management Team and Appoints new CFO
DJ
06/09DGAP-DD : Fresenius Medical Care AG & Co. KGaA english
DJ
06/08FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs reiterates its Buy rating
MD
06/02ANALYST RECOMMENDATIONS : Bank of America, Bodycote, Chevron, Dow Inc, Ferguson...
06/01FMC FRESENIUS MEDICAL CARE AG & CO K : Jefferies gives a Sell rating
MD
06/01FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs maintains a Buy rating
MD
06/01FRESENIUS SE  : Goldman Sachs reaffirms its Buy rating
MD
05/31FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
05/28FRESENIUS SE & CO. KGAA  : Notification and public disclosure of transactions by..
EQ
05/26DGAP-DD : Fresenius Medical Care AG & Co. KGaA english
DJ
05/26PRESS RELEASE : Immatics Announces Changes to its Board of Directors
DJ
05/25FRESENIUS SE & CO. KGAA  : Dividends
CO
05/24SECTOR UPDATE : Health Care Stocks Still Narrowly Higher in Late Regular-Hours T..
MT
05/24SECTOR UPDATE : Health Care Stocks Higher in Moderation
MT
More news
News in other languages on FRESENIUS SE & CO. KGAA
06/15MÄRKTE EUROPA/DAX vor Fed-Sitzung weiter freundlich
06/14Nestlé fait entrer un représentant du WWF au sein d'un de ses organes
06/14STUDI LEGALI  : Legance con Ihg in cessione ramo dialisi
06/11MILAN STOCK EXCHANGE : Borsa Milano indici quasi fermi, strappano Reno Medici, I..
06/11MÄRKTE EUROPA/Gut behauptet - fallende Renditen stützen
More news
Analyst Recommendations on FRESENIUS SE & CO. KGAA
More recommendations
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | FRE | DE0005785604 | MarketScreener
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 47,60 €
Last Close Price 45,56 €
Spread / Highest target 75,6%
Spread / Average Target 4,48%
Spread / Lowest Target -61,2%
EPS Revisions
Managers and Directors
NameTitle
Stephan Sturm President & Chief Executive Officer
Rachel Clare Empey Chief Financial Officer
Wolfgang Kirsch Chairman-Supervisory Board
Sebastian Biedenkopf Legal, Compliance & Human Resources Director
Klaus-Peter Müller Independent Member-Supervisory Board
Sector and Competitors